Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 3, 2010, Pages 315-319

  Ferrara, Joseph ^a   Diamond, Alan ^a   Hunter, Christine ^a   Davidson, Anthony ^a   Almaguer, Michael ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY EQUILIBRIUM; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; FEMALE; HUMAN; INDEPENDENCE; LIFE SATISFACTION; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SUBTHALAMIC NUCLEUS; WALKING;

ACTIVITIES OF DAILY LIVING; AGED; DEEP BRAIN STIMULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SUBTHALAMIC NUCLEUS;

EID: 77649127518     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.184127     Document Type: Article

References (51)

1. Benabid AL, Chabardes S, Mitrofanis J, et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009;8:67-81.
2. Kenney C, Simpson R, Hunter C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007;106:621-5.
3. Weaver FM, Follett K, Stern M, et al. CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
4. Parsons TD, Rogers SA, Braaten AJ, et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006;5:578-88.
5. York MK, Dulay M, Macias A, et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatr 2008;79:789-95.
6. Alberts JL, Voelcker-Rehage C, Hallahan K, et al. Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients. Brain 2008;131:3348-60.
7. Williams A, Arzola GM, Strutt AM, et al. A controlled study of the long-term cognitive outcome of bilateral subthalamic nucleus deep brain stimulation. Neurology 2009;72 (Suppl 3):A221.
8. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008;131:2720-8.
9. Schüpbach M, Gargiulo M, Welter ML, et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology 2006;66:1811-6.
10. Deuschl G, Herzog J, Kleiner-Fisman G, et al. Deep brain stimulation: postoperative issues. Mov Disord 2006;21(Suppl 14):S219-37.
11. Den Oudsten BL, Van Heck GL, De Vries J. Quality of life and related concepts in Parkinson's disease: a systematic review. Mov Disord 2007;22:1528-37.
12. The Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002;17:60-7.
13. Lee MA, Walker RW, Hildreth AJ, et al. Individualized assessment of quality of life in idiopathic Parkinson's disease. Mov Disord 2006;21:1929-34.
14. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008;23:1420-7.
15. Rahman S, Griffin HJ, Quinn NP, et al. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 2008;23:1428-34.
16. Den Oudsten BL, Van Heck GL, De Vries J. The suitability of patient-based measures in the field of Parkinson's disease: a systematic review. Mov Disord 2007;22:1390-401.
17. WHOQOL group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403-9.
18. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatr 2000;69:308-12.
19. Montel SR, Bungener C. Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus. Surg Neurol 2008. Published Online First: Sep 9. doi:10.1016/j.surneu.2008.05.026.
20. Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res 1999;8:447-59.
21. Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatr 2005;76:1188-93.
22. Martinez-Martin P, Deuschl G. Effect of medical and surgical interventions on health-related quality of life in Parkinson's disease. Mov Disord 2007;22:757-65.
23. Lezcano E, Gomez-Esteban JC, Zarranz JJ, et al. Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus. Eur J Neurol 2004;11:451-4.
24. Erola T, Karinen P, Heikkinen E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients. Parkinsonism Relat Disord 2005;11:89-94.
25. Gronchi-Perrin A, Viollier S, Ghika J, et al. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease? Mov Disord 2006;21:1465-8.
26. Siderowf A, Jaggi JL, Xie SX, et al. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease. Mov Disord 2006;21:746-53.
27. Martínez-Martín P, Valldeoriola F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002;17:372-7.
28. Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol 2005;252:583-8.
29. Deuschl G, Schade-Brittinger C, Krak P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
30. Zahodne LB, Okun MS, Foote KD, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol 2009. Published Online First: Apr 12. doi:10.1007/s00415-009-5121-7.
31. Just H, Ostergaard K. Health-related quality of life in patients with advanced Parkinson s disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 2002;17:539-45.
32. Lagrange E, Krack P, Moro E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 2002;59:1976-8.
33. Spottke EA, Volkmann J, Lorenz D, et al. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. J Neurol 2002;249:759-66.
34. Kuehler A, Henrich G, Schroeder U, et al. A novel quality of life instrument for deep brain stimulation in movement disorders. J Neurol Neurosurg Psychiatr 2003;74:1023-30.
35. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 1992;55:181-4.
36. Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-84.
37. Krabbe PF, Weijnen T. Guidelines for analyzing and reporting EQ-5D outcomes. In: Brooks R, Rabin R, De Charro F, eds. The measurement and valuation of health status using EQ-5D: the European perspective. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2003.
38. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
39. Goldbeck L, Schmitz TG, Besier T, et al. Life satisfaction decreases during adolescence. Qual Life Res 2007;16:969-79.
40. Yesavage JA, Brink TL, Rose TL. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37-49.
41. Fahn S, Elton RL. for the members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, eds. Recent developments in Parkinson's disease. London, England: Macmillan Publishing Co Inc, 1987:153-63.
42. Parkinson Study Group. Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. Arch Neurol 2001;58:1660-8.
43. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
44. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
45. Parkin SG, Gregory RP, Scott R, et al. Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: a case series of 115. Mov Disord 2002;17:682-92.
46. Tröster AI, Fields JA, Wilkinson S, et al. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 2003;80:43-7.
47. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008;7:605-14.
48. Valldeoriola F, Morsi O, Tolosa E, et al. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord 2007;22:2183-91.
49. Esselink RA, De Bie RM, De Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201-7.
50. Slowinski JL, Putzke JD, Uitti RJ, et al. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg 2007;106:626-32.
51. Volkmann J, Albanese A, Kulisevsky J, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord 2009;24:1154-61.